During experiments in animal models, researchers at the University of Kansas have discovered a possible new approach to immunization against Alzheimer's disease (AD). Their method uses a recombinant ...
An active vaccine against a small piece of the Aβ42 protein is both safe and tolerable in patients with mild to moderate Alzheimer's disease (AD), according to Phase 1 trial results published in the ...
During experiments in animal models, researchers have discovered a possible new approach to immunization against Alzheimer's disease. Their method uses a recombinant methionine (Met)-rich protein ...
In a recent study published in Jornal de Pediatria, researchers explored active and passive vaccination among children against respiratory syncytial virus (RSV). Study: Current strategies and ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...
In an unbiased exploratory screen of antibodies directed against brain proteins, we found in AD patients high serum levels of antibodies against ankG. AnkG expression was high in both cortical neurons ...
Vertical transmission of hepatitis B virus (HBV) from mother to child is a major route of spread, but debate continues over whether perinatal vaccine administration alone adequately prevents ...
(RTTNews) - Novavax, Inc. (NVAX) said its partner SK bioscience has received expanded manufacturing and marketing approval from the Korean Ministry of Food and Drug Safety for Nuvaxovid for use as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback